Sibutramine: all 23 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Studying the Effects of Sibutramine on Eating BehaviorTerminatedNCT01170364Phase 4Results posted
- A Weight Loss Study in Overweight Men and WomenTerminatedNCT00993421Phase 2Results posted
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped CareCompletedNCT00829283Not applicableResults posted
- Treatment of Binge Eating in Obese Patients in Primary CareCompletedNCT00537810Phase 4Results posted
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese PatientsCompletedNCT00234832Phase 3Results posted
- LOSS- Louisiana Obese Subjects StudyTerminatedNCT00115063Phase 4Results posted
- Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary ObesityCompletedNCT05821543Phase 4
- A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese SubjectsCompletedNCT01597609Phase 1
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)Status unknownNCT01475019Phase 4
- Assess the Additional Weight Loss Effect of Orlistat Used in Combination With SibutramineCompletedNCT01184560Not applicable
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)CompletedNCT00914212Phase 1
- Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) PatientsCompletedNCT00729963Phase 4
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationCompletedNCT00677391Phase 3
- Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOSCompletedNCT00463112Phase 4
- Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited GenesCompletedNCT00433641Phase 4
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedNCT00402584Phase 3
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedNCT00402077Phase 2
- Pharmacodynamic Effects of Sibutramine on Gastric Function in ObesityCompletedNCT00330525Phase 2
- A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.CompletedNCT00261911Phase 3
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.CompletedNCT00234988Phase 4
- A Comparative Study of KES524 in Patients With Obesity DiseaseCompletedNCT00165685Phase 3
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCompletedNCT00044187Phase 4
- Sibutramine to Reduce Weight Gain and Improve Smoking Cessation RatesCompletedNCT00037752Not applicable